Star Vision Research

Burleson, Texas 76028

1 studies enrolling now · 6 studies all time

What they study most

Diabetic Retinopathy, Geographic Atrophy, Neovascular Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration (nAMD), Wet Age Related Macular Degeneration, Wet Age-related Macular Degeneration, wAMD

Studies at this site

• A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56 — Running, not enrolling
• A Study in Adults With Geographic Atrophy — Starting soon
• Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD) — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR) — Completed
• A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration — Running, not enrolling